NAME Dr Charles Bailey
CANCER TYPE General
INSTITUTION The Centenary Institute
STATE New South Wales
GRANT TYPE $200,000
PROJECT TYPE Research
Cellular Sabotage:
This project explores disrupting DNA architecture in order to kill cancer. Small molecules called 'sabots' that specifically inhibit or 'sabotage' the DNA/protein network that controls DNA architecture in cells have been developed. The project aims to develop cellular sabotage as a new cancer therapy strategy.
